West Pharmaceutical Servs (NYSE: WST)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-28 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.120 | 2.300 | 0.1800 | ||||
REV | 720.920M | 720.000M | -920.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of West Pharmaceutical Servs (NYSE: WST) through any online brokerage.
Other companies in West Pharmaceutical Servs’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for West Pharmaceutical Servs (NYSE: WST) was reported by Keybanc on Friday, April 29, 2022. The analyst firm set a price target for 400.00 expecting WST to rise to within 12 months (a possible 32.58% upside). 2 analyst firms have reported ratings in the last year.
The stock price for West Pharmaceutical Servs (NYSE: WST) is $301.7 last updated June 24, 2022, 8:00 PM UTC.
The next West Pharmaceutical Servs (WST) dividend date is projected to be Tuesday, July 19, 2022.
West Pharmaceutical Servs’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for West Pharmaceutical Servs.
West Pharmaceutical Servs is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.